Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Creative Medical Technology Holdings, Inc. (CELZ)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.5300+0.1000 (+4.12%)
At close: 04:00PM EST
2.5100 -0.02 (-0.79%)
After hours: 07:58PM EST
Advertisement

Creative Medical Technology Holdings, Inc.

211 East Osborn Road
Phoenix, AZ 85012
United States
833 336 7636
https://www.creativemedicaltechnology.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Timothy WarbingtonChairman, Pres & CEON/AN/A1962
Mr. Donald DickersonSr. VP, CFO & DirectorN/AN/A1965
Dr. Courtney BartlettHead of Clinical Devel. of Pipeline Therapeutic ProductsN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.

Corporate Governance

Creative Medical Technology Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement